Rethinking neurodegenerative diseases: neurometabolic concept linking lipid oxidation to diseases in the central nervous system.

Autor: Helgudóttir SS; 2N Pharma ApS, NOVI Science Park, Aalborg, Denmark., Mørkholt AS; 2N Pharma ApS, NOVI Science Park, Aalborg, Denmark., Lichota J; Molecular Pharmacology Group, Department of Health Science and Technology, Aalborg University, Aalborg, Denmark., Bruun-Nyzell P; 2N Pharma ApS, NOVI Science Park, Aalborg, Denmark., Andersen MC; Molecular Pharmacology Group, Department of Health Science and Technology, Aalborg University, Aalborg, Denmark., Kristensen NMJ; Molecular Pharmacology Group, Department of Health Science and Technology, Aalborg University, Aalborg, Denmark., Johansen AK; Molecular Pharmacology Group, Department of Health Science and Technology, Aalborg University, Aalborg, Denmark., Zinn MR; Molecular Pharmacology Group, Department of Health Science and Technology, Aalborg University, Aalborg, Denmark., Jensdóttir HM; Molecular Pharmacology Group, Department of Health Science and Technology, Aalborg University, Aalborg, Denmark., Nieland JDV; 2N Pharma ApS, NOVI Science Park, Aalborg, Denmark.; Molecular Pharmacology Group, Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.

Publikováno v: Neural regeneration research [Neural Regen Res] 2024 Jul 01; Vol. 19 (7), pp. 1437-1445. Date of Electronic Publication: 2023 Nov 08.